NCT06933212 · RECRUITING
Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.
This trial is testing whether a Mediterranean diet, boosted with either extra virgin olive oil or walnuts, affects stroke risk and cognitive decline in people with two specific vascular brain conditions: CADASIL and Cerebral Amyloid Angiopathy (CAA). It first observes patients' current eating habits, then intervenes with a structured diet. The phase is unspecified, so this appears to be an early or exploratory study — not yet proven or approved as a treatment.
You may qualify if
- The study will include individuals of both sexes aged 18 years or older with a diagnosis of CADASIL (confirmed genetically by the presence of the NOTCH3 gene mutation) or possible/probable CAA (defined according to the Boston 2.0 criteria). All participants must provide informed consent for the use of demographic, clinical, and nutritional data for scientific purposes in an anonymous form
You're excluded if
- na
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-04-18